MFS
ARLZ

MSI Financial Services’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

MSI Financial Services’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Hold
1,075
– – ﹤0.01% 3200
2016
Q3 		$5K Buy
1,075
+1,000
+1,333% +$4.56K ﹤0.01% 3197
2016
Q2 		$0 Hold
75
– – ﹤0.01% 4326
2016
Q1 		$0 Buy
+75
New +$387 ﹤0.01% 4323

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
TLCM
Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MSI Financial Services's ARLZ Position: Q4 2016 in Review

MSI Financial Services held its Aralez Pharmaceuticals Inc. (ARLZ) position steady in Q4 2016 at 1,075 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

MSI Financial Services first reported a position in ARLZ in Q1 2016 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold ARLZ as of Q4 2016.

  • MSI Financial Services held 1,075 shares of Aralez Pharmaceuticals Inc. worth $5K as of Q4 2016.
  • MSI Financial Services left its Aralez Pharmaceuticals Inc. share count unchanged in Q4 2016.
  • Aralez Pharmaceuticals Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3200 holding.
  • MSI Financial Services first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.